1. Home
  2. HFWA vs CGEM Comparison

HFWA vs CGEM Comparison

Compare HFWA & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$27.78

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$13.44

Market Cap

904.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
CGEM
Founded
1927
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
904.7M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
HFWA
CGEM
Price
$27.78
$13.44
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$30.50
$30.13
AVG Volume (30 Days)
197.0K
1.0M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
3.53%
N/A
EPS Growth
58.06
N/A
EPS
0.48
N/A
Revenue
N/A
N/A
Revenue This Year
$45.85
N/A
Revenue Next Year
$7.83
$5.20
P/E Ratio
$57.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.32
$5.68
52 Week High
$28.98
$16.74

Technical Indicators

Market Signals
Indicator
HFWA
CGEM
Relative Strength Index (RSI) 58.25 42.21
Support Level $26.26 $13.55
Resistance Level $28.26 $16.31
Average True Range (ATR) 0.64 1.03
MACD 0.06 -0.14
Stochastic Oscillator 91.76 14.94

Price Performance

Historical Comparison
HFWA
CGEM

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Share on Social Networks: